Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2023);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;%Female;Overton;SDG;Country;Region;Publisher;Coverage;Categories;Areas 1;7700153108;"International Journal of Nanomedicine";journal;"11782013, 11769114";1,273;Q1;179;443;1559;33731;12840;1554;6,74;76,14;43,56;0;229;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2006-2023";"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1)";"Biochemistry, Genetics and Molecular Biology; Chemical Engineering; Chemistry; Materials Science; Medicine; Pharmacology, Toxicology and Pharmaceutics" 2;19700175230;"Drug Design, Development and Therapy";journal;"11778881";0,999;Q1;94;271;1141;13688;5855;1136;4,89;50,51;45,28;0;86;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2007-2023";"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)";"Pharmacology, Toxicology and Pharmaceutics" 3;19700175015;"Infection and Drug Resistance";journal;"11786973";0,743;Q2;65;698;1733;27973;5784;1701;2,87;40,08;44,32;0;419;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2009-2023";"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)";"Medicine; Pharmacology, Toxicology and Pharmaceutics" 4;19700174905;"Diabetes, Metabolic Syndrome and Obesity";journal;"11787007";0,835;Q2;64;368;1259;16211;4174;1243;2,88;44,05;48,16;0;309;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2009-2023";"Internal Medicine (Q2); Pharmacology (Q2)";"Medicine; Pharmacology, Toxicology and Pharmaceutics" 5;19700175819;"Patient Preference and Adherence";journal;"1177889X";0,647;Q1;67;301;777;12103;1891;764;2,18;40,21;52,17;0;143;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2007-2023";"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)";"Medicine; Pharmacology, Toxicology and Pharmaceutics; Social Sciences" 6;4700152233;"Therapeutics and Clinical Risk Management";journal;"11766336, 1178203X";0,752;Q1;70;90;357;4189;986;352;2,35;46,54;38,52;0;35;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2006-2023";"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)";"Chemical Engineering; Medicine; Pharmacology, Toxicology and Pharmaceutics; Social Sciences" 7;19700175029;"Pharmacogenomics and Personalized Medicine";journal;"11787066";0,508;Q3;37;95;303;4240;582;301;1,94;44,63;42,08;0;59;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2009-2023";"Molecular Medicine (Q3); Pharmacology (Q3)";"Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics" 8;21100781436;"Journal of Experimental Pharmacology";journal;"11791454";0,778;Q2;23;41;153;1868;578;152;3,76;45,56;30,72;0;16;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2010, 2012-2023";"Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)";"Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics" 9;10900153302;"Biomarker Insights";journal;"11772719";0,974;Q1;40;9;67;468;246;59;3,34;52,00;50,00;0;3;New Zealand;Pacific Region;"Libertas Academica Ltd.";"2006-2023";"Pharmacology (Q1); Biochemistry (medical) (Q2); Molecular Medicine (Q2)";"Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics" 10;19700175086;"Drug, Healthcare and Patient Safety";journal;"11791365";0,571;Q3;30;16;76;757;205;76;2,52;47,31;38,71;0;5;New Zealand;Pacific Region;"Dove Medical Press Limited";"2009-2023";"Health Policy (Q2); Pharmacology (Q3)";"Medicine; Pharmacology, Toxicology and Pharmaceutics" 11;19700178100;"Nanotechnology, Science and Applications";journal;"11778903";0,848;Q1;35;5;26;302;170;26;5,53;60,40;61,11;0;4;New Zealand;Pacific Region;"Dove Medical Press Limited";"2010-2012, 2014-2023";"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Nanoscience and Nanotechnology (Q2)";"Chemical Engineering; Engineering; Materials Science; Pharmacology, Toxicology and Pharmaceutics" 12;19383;"Fluoride - Quarterly Reports";journal;"22534083, 00154725";0,178;Q4;51;45;74;1579;45;65;0,49;35,09;56,05;0;12;New Zealand;Pacific Region;"International Society for Fluoride Research";"1973-2023";"Dentistry (miscellaneous) (Q3); Agricultural and Biological Sciences (miscellaneous) (Q4); Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)";"Agricultural and Biological Sciences; Biochemistry, Genetics and Molecular Biology; Chemistry; Dentistry; Environmental Science; Medicine; Pharmacology, Toxicology and Pharmaceutics" 13;19700175785;"Open Access Journal of Clinical Trials";journal;"11791519";0,561;Q1;15;1;15;54;31;14;1,11;54,00;37,50;0;0;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2009-2023";"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)";"Medicine; Pharmacology, Toxicology and Pharmaceutics"